SCHEDULE 13G/A: Dodge & Cox Discloses 9.6% Passive Stake in Zimmer Biomet Holdings

Investment adviser Dodge & Cox has reported a 9.6% passive beneficial ownership stake in Zimmer Biomet Holdings, Inc. as of December 31, 2024.

Summary

• Dodge & Cox, an investment adviser based in San Francisco, CA, has filed an Amendment No. 2 to Schedule 13G regarding its beneficial ownership in Zimmer Biomet Holdings, Inc.
• As of December 31, 2024, Dodge & Cox beneficially owned an aggregate of 19,118,436 shares of Zimmer Biomet Holdings, Inc. Common Stock.
• This ownership represents 9.6% of the class of securities.
• Dodge & Cox holds sole voting power over 18,037,511 shares and sole dispositive power over 19,118,436 shares.
• No shared voting or dispositive power was reported.
• Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, holds an interest of 12,523,600 shares, which constitutes 6.3% of the class of securities reported.

Sentiment

Score: 7

Explanation: The filing indicates a significant, passive ownership stake by a reputable institutional investor, suggesting confidence in the issuer's long-term prospects without any negative implications from the filing itself.

Positives

• A significant institutional investor, Dodge & Cox, maintains a substantial beneficial ownership stake (9.6%) in Zimmer Biomet Holdings, indicating continued confidence in the company's long-term prospects.
• The investment is held in the ordinary course of business and not for the purpose of changing or influencing control, suggesting a stable, long-term investment perspective from a reputable firm.

Risks

• The filing is a Schedule 13G, indicating a passive investment. This means Dodge & Cox does not intend to influence or change control of Zimmer Biomet Holdings, which may limit their ability to advocate for shareholder interests if management decisions are not aligned with their views.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from Zimmer Biomet Holdings, Inc. or Dodge & Cox regarding the issuer's future performance.

Industry Context

Zimmer Biomet Holdings operates in the medical device industry, specializing in musculoskeletal healthcare. The continued significant investment by a major institutional fund like Dodge & Cox suggests a positive long-term view on the company's position within this sector, which is characterized by ongoing demand for orthopedic and medical solutions.

Stakeholder Impact

• Shareholders: The continued significant stake held by a major institutional investor like Dodge & Cox may be viewed as a positive signal of institutional confidence in Zimmer Biomet Holdings, potentially reinforcing investor sentiment.

Key Dates

Recommendation

Keywords

Zimmer Biomet Holdings, Dodge & Cox, Schedule 13G, beneficial ownership, institutional investment, passive investment, common stock, medical devices, orthopedics